Basic Investigations in Brain Remodeling
Basic Investigations in Brain Remodeling
批准号:
7252233
负责人:
ZHENG GANG ZHANG
金额:
$36.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2012-03-31
关键词:
1-Phosphatidylinositol 3-KinaseAdultAftercareAttenuatedBlood VesselsBrainCXCR4 ReceptorsCXCR4 geneCell CycleCell Cycle KineticsCell divisionCellsClinical ResearchCouplingCyclic GMPCyclin-Dependent Kinase InhibitorDataDevelopmentEndothelial CellsEventFosteringGelatinase AGelatinase BGenesImmigrationIn VitroInvestigationLeadLengthMMP9 geneMatrix MetalloproteinasesMeasuresMediatingMethodsMicroscopyMitoticMolecularNervous System PhysiologyPathway interactionsPhasePhosphodiesterase InhibitorsProcessProteinsRecovery of FunctionRetroviral VectorSignal PathwaySignal TransductionSmall Interfering RNAStem cellsStrokeStromelysin 1TestingTimeangiogenesisbasedaydesignin vivoinhibitor/antagonistmigrationnerve stem cellneuroblastneurogenesisneurorestorationnovelphosphodiesterase Vphosphoric diester hydrolasepreclinical studyprogenitorrelating to nervous systemresearch studyrestorationsildenafilstroke recoverystroke therapy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Treatment of stroke with a selective inhibitor of phosphodiesterase type 5 (PDE5), e.g.sildenafil,
significantly promotes functional recovery concomitant with significant increases of neurogenesis and
angiogenesis when the treatment is initiated 1 or 7 days after stroke onset. In this application, we seek to
elucidate fundamental mechanisms of neurogenesis, neuroblast migration and the coupling of
neurogenesis and angiogenesis after stroke with and without treatment with sildenafil as the
neurorestorative agent. Our hypotheses are that sildenafil mediated increases of cGMP levels in stroke
brain: 1) promote proliferation of neural progenitor cells via shortening the length of the cell cycle which
results from a decreased expression of cyclin-dependent kinase inhibitors; 2) enhance neuroblast
migration towards the ischemic boundary regions via increasing expression of stromal-derived factor-la
(SDF-1a), CXCR4 and matrix metalloproteinases (MMPs); 3) foster angiogenesis which generates a
permissive niche to promote neurogenesis and to guide neuroblast migration towards the ischemic
boundary regions; and 4) the PI3K/Akt signaling pathway mediates sildenafil-enhanced neurogenesis and
neuroblast migration. The proposed experiments have been designed to test these hypotheses. We will
investigate whether sildenafil amplifies cell cycle kinetics and the orientation of cell division that regulate
the proliferation and differentiation of neural progenitor and stem cells in the subventricular zone. Using
retroviral vector, siRNA, and time-lapse microscopy, we will delve into the molecular mechanisms, e.g.
SDF-1/CXCR4 and MMPs, which promote neuroblast migration in the ischemic brain after treatment with
sildenafil. To examine the effects of sildenafil-induced angiogenesis on neurogenesis and neuroblast
migration, we will measure the interaction between angiogenesis and neurogenesis and proteins secreted
by the endothelial cells. By blocking SDF-1a and MMPs, we will examine whether SDF-1a and MMPs
secreted by endothelial cells mediate neuroblast migration. Using specific inhibitors, we will investigate
whether blocking the PI3K/Akt signaling pathway attenuates the effects of sildenafil on neurogenesis,
neuroblast migration and angiogenesis. These basic scientific studies will elucidate the mechanisms how
the brain remodels itself after stroke and how cGMP amplifies this process in the adult brain, which may
lead to novel methods to facilitate brain remodeling during stroke recovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exosome therapy for acute stroke with large artery occlusion
-
批准号:9759025
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2019
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Exosome therapy for acute stroke with large artery occlusion
-
批准号:10093165
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2019
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Exosome therapy for acute stroke with large artery occlusion
-
批准号:10335192
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2019
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Exosome therapy for acute stroke with large artery occlusion
-
批准号:10550210
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2019
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Exosomes and platinum-induced peripheral neuropathy
-
批准号:10433899
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2018
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Exosomes and platinum-induced peripheral neuropathy
-
批准号:10199955
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2018
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Ac-SDKP for Treatment of Acute Stroke
-
批准号:8504109
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2013
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Ac-SDKP for Treatment of Acute Stroke
-
批准号:9037066
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2013
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Ac-SDKP for Treatment of Acute Stroke
-
批准号:8656455
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2013
-
负责人:ZHENG GANG ZHANG
-
依托单位:
MicroRNAs and neurogenesis after stroke
-
批准号:8329603
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2011
-
负责人:ZHENG GANG ZHANG
-
依托单位:
MicroRNAs and neurogenesis after stroke
-
批准号:8892273
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2011
-
负责人:ZHENG GANG ZHANG
-
依托单位:
MicroRNAs and neurogenesis after stroke
-
批准号:8693034
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2011
-
负责人:ZHENG GANG ZHANG
-
依托单位:
MicroRNAs and neurogenesis after stroke
-
批准号:8237708
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2011
-
负责人:ZHENG GANG ZHANG
-
依托单位:
MicroRNAs and neurogenesis after stroke
-
批准号:8516125
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2011
-
负责人:ZHENG GANG ZHANG
-
依托单位:
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: NEUROSCIENCE, BLOOD STUDIES
-
批准号:7166210
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2005
-
负责人:ZHENG GANG ZHANG
-
依托单位:
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: HYPERTENSION
-
批准号:7166209
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2005
-
负责人:ZHENG GANG ZHANG
-
依托单位:
Radiance 2100 AG-2Q Confocal Multiphoton System
-
批准号:6877455
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2005
-
负责人:ZHENG GANG ZHANG
-
依托单位:
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: STROKE, BRAIN TUMOR
-
批准号:7166207
-
项目类别:
-
资助金额:$16.5万
-
财政年份:2005
-
负责人:ZHENG GANG ZHANG
-
依托单位:
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: GLIOMA RESEARCH
-
批准号:7166208
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2005
-
负责人:ZHENG GANG ZHANG
-
依托单位:
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: ADULT ANIMAL STEM CELLS, PLASTICITY, TBI
-
批准号:7166206
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2005
-
负责人:ZHENG GANG ZHANG
-
依托单位:
海外基金